Literature DB >> 18508576

Resistance mechanisms to cancer chemotherapy.

Kelly Marie Redmond1, Timothy Richard Wilson, Patrick Gerard Johnston, Daniel Broderick Longley.   

Abstract

Resistance to chemotherapy ('drug resistance') is a fundamental problem that limits the effectiveness of many chemotherapies currently used to treat cancer. Drug resistance can occur due to a variety of mechanisms, such as increased drug inactivation, drug efflux from cancer cells, enhanced repair of chemotherapy-induced damage, activation of pro-survival pathways and inactivation of cell death pathways. In this article, we review some of the major mechanisms of drug resistance and discuss how new molecularly-targeted therapies are being increasingly used to overcome these resistance mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508576     DOI: 10.2741/3070

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  42 in total

1.  Cancer: drug-tolerant insurgents.

Authors:  Paul Workman; Jon Travers
Journal:  Nature       Date:  2010-04-08       Impact factor: 49.962

2.  Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS.

Authors:  Guangchang Zhou; Faraz Khan; Qing Dai; Juliesta E Sylvester; Stephen J Kron
Journal:  Mol Biosyst       Date:  2012-07-06

3.  Parameter non-identifiability of the Gyllenberg-Webb ODE model.

Authors:  Niklas Hartung
Journal:  J Math Biol       Date:  2013-08-30       Impact factor: 2.259

4.  Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.

Authors:  Niels F Jensen; Jan Stenvang; Mette K Beck; Barbora Hanáková; Kirstine C Belling; Khoa N Do; Birgitte Viuff; Sune B Nygård; Ramneek Gupta; Mads H Rasmussen; Line S Tarpgaard; Tine P Hansen; Eva Budinská; Per Pfeiffer; Fred Bosman; Sabine Tejpar; Arnaud Roth; Mauro Delorenzi; Claus L Andersen; Maria U Rømer; Nils Brünner; José M A Moreira
Journal:  Mol Oncol       Date:  2015-02-24       Impact factor: 6.603

5.  Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer.

Authors:  Munisha Smalley; Siva Kumar Natarajan; Jayanta Mondal; Douglas Best; David Goldman; Basavaraja Shanthappa; Moriah Pellowe; Chinmayee Dash; Tanmoy Saha; Sachin Khiste; Nithya Ramadurai; Elliot O Eton; Joshua L Smalley; Andrew Brown; Allen Thayakumar; Mamunur Rahman; Kazuya Arai; Mohammad Kohandel; Shiladitya Sengupta; Aaron Goldman
Journal:  Cancer Res       Date:  2020-10-19       Impact factor: 12.701

Review 6.  Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.

Authors:  Hariharan Easwaran; Hsing-Chen Tsai; Stephen B Baylin
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

7.  A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.

Authors:  Sreenath V Sharma; Diana Y Lee; Bihua Li; Margaret P Quinlan; Fumiyuki Takahashi; Shyamala Maheswaran; Ultan McDermott; Nancy Azizian; Lee Zou; Michael A Fischbach; Kwok-Kin Wong; Kathleyn Brandstetter; Ben Wittner; Sridhar Ramaswamy; Marie Classon; Jeff Settleman
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

8.  Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.

Authors:  Yongmei Feng; Eric Lau; Marzia Scortegagna; Chelsea Ruller; Surya K De; Elisa Barile; Stan Krajewski; Pedro Aza-Blanc; Roy Williams; Anthony B Pinkerton; Michael Jackson; Lynda Chin; Maurizio Pellecchia; Marcus Bosenberg; Ze'ev A Ronai
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-02       Impact factor: 4.693

Review 9.  Therapeutic cancer vaccines in combination with conventional therapy.

Authors:  Mads Hald Andersen; Niels Junker; Eva Ellebaek; Inge Marie Svane; Per Thor Straten
Journal:  J Biomed Biotechnol       Date:  2010-06-29

10.  Arylthioindoles: Promising compounds against cancer cell proliferation.

Authors:  Vincenzo Giansanti; Francesco Piscitelli; Tania Camboni; Ennio Prosperi; Giuseppe LA Regina; Michele Parks; Romano Silvestri; Anna Ivana Scovassi
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.